People who start treatment with Tysabri (natalizumab) soon after being diagnosed with multiple sclerosis (MS) are at a lower risk of relapse in the long term compared with patients who start on less effective disease-modifying therapies (DMT), a study has found. Continue reading →

image: http://www.mscare.org/2024 Credit: CMSC The leading research and educational conference for multiple sclerosis healthcare professionals in North America, the Consortium of Multiple Sclerosis Centers (CMSC) 38th Annual Meeting, returns to Nashville, Tennessee, May 29-June 1, 2024 at the Music City Center. The conference is renowned for its emphasis on reaching the interprofessional team involved in MS care, with learning opportunities for physicians, advanced practice clinicians, nursing professionals, pharmacists, mental health and rehabilitation specialists, dietitians, researchers, advocates and other members of the healthcare team involved in the management of people with MS. The CMSC Annual Meeting will feature daily opening lectures with some of the top minds in multiple sclerosis as well as accredited symposia, courses, poster sessions, and platform presentations relevant to all MS healthcare professionals Continue reading →

This is a video synopsis/summary of a panel discussion involving Ahmed Obeidat, MD, PhD; Riley Bove, MD; Stephen Krieger, MD; and Erin Longbrake, MD, PhD. In the discussion, the topic of treating multiple sclerosis (MS) in older individuals is explored. There's recognition that chronological age alone doesn't determine treatment decisions, as individuals' health status and disease mechanisms vary Continue reading →

It took years for Gregory Sonn to receive an MS diagnosis. He first noticed symptoms while traveling in his 20s Continue reading →

Multiple sclerosis (MS) is a neurodegenerative disorder in which a persons immune system attacks the protective sheath (myelin) covering the nerve fibres of the brain and spinal cord. Although MS is a progressive disease, leading to the permanent damage of the nerve fibres and potentially severe disability, there are many different treatment approaches that are designed to reduce relapses and increase time between attacks, ease debilitating symptoms and ultimately slow down disease progression. Continue reading →